Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cantrixil Phase I Study Progresses To Next Stage 2018-10-10 15:15
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval 2018-10-10 14:49
Australian Health Manufacturer ATP Science Achieves ISO 9001 Certification 2018-10-09 12:08
Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study 2018-10-08 21:00
Lifescan Announces Future Innovation at EASD: The OneTouch Verio Reflect(TM) Blood Glucose Meter featuring Blood Sugar Mentor(TM) 2018-10-05 00:00
Merck Opens M Lab(TM) Collaboration Center in Sao Paulo, Brazil 2018-10-04 20:00
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI 2018-10-04 15:43
Accera closes new investment led by Asia's leading agribusiness group, Wilmar, and rebrands as Cerecin 2018-10-04 15:00
ProPak Launches in the Philippines 2018-10-04 11:00
Ping An Good Doctor Establishes Strategic Partnership with CR Sanjiu to Jointly Promotes Pharmaceutical New Retail 2018-10-03 18:00
Hong Kong Department of Health Approves Biktarvy(R) (bictegravir, emtricitabine, tenofovir alafenamide) 2018-10-03 16:55
Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia 2018-10-03 14:03
Ping An Good Doctor Forms Joint Venture with Grab to Provide One-Stop Healthcare Services in Southeast Asia 2018-10-03 10:45
Ryzodeg® Offers a Simpler Solution With Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin Glargine U100 Plus Insulin Aspart 2018-10-02 17:59
People With Diabetes May Achieve Improved Glycaemic Control With Tresiba(R) Versus Glargine U100, Without an Increase in Hypoglycaemia 2018-10-02 17:59
Office of Generic Drugs (OGD/FDA) Awards $1M FDA Contract to CUBRC and EpiVax for Demonstration and Validation of Immunogenicity Risk Assessment Methods for Generic Peptide Drugs and Their Impurities 2018-10-02 13:00
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share 2018-09-29 05:15
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset 2018-09-28 21:00
TransThera Biosciences Granted IND Approval from FDA to Soon Start Clinical Trials Targeting TNBC 2018-09-28 20:00
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration 2018-09-28 20:00
1 347 348 349 350 351 412